Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]

NCT04251052 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT04251052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04251052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
Lead sponsor
NRG Oncology
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2020
Completion date
June 30, 2047
Enrollment
1,956 (estimated)
Sites
574

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian carcinoma